Inhibikase Therapeutics, Inc.
New Filing
CIK: 0001750149·Pharmaceuticals·DELAWARE·Filed: Jun 4, 2024
Total Offering
$7,999,999
Amount Sold
$0
Investors
1
First Sale
May 20, 2024
Offering Details
- Type
- Equity, Option to Acquire, Security to be Acquired
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Milton H. Werner | Related Person |
| Dennis Berman | Related Person |
| Roy Freeman | Related Person |
| Paul Grint | Related Person |
| Gisele Dion | Related Person |
| Garth Lees-Rolfe | Related Person |
Company
SEC Filing
0001750149-24-000002
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free